Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome

Eur J Obstet Gynecol Reprod Biol. 2016 Dec:207:214-219. doi: 10.1016/j.ejogrb.2016.08.026. Epub 2016 Aug 12.

Abstract

Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive aged women and is characterized by two of the following three features: oligoovulation or anovulation, clinical and/or biochemical signs of hyperandrogenism, or polycystic ovaries.

Summary: It has been demonstrated that PCOS includes a complex number of systemic symptoms in addition to symptoms related to the reproductive apparatus. It has been associated with obesity, metabolic syndrome, type 2 diabetes and an increased risk of cardiovascular disease. Several clinical and basic studies have investigated the link between PCOS and the cardiovascular disease risk, which seems to be due to blunted lipid/glucose metabolism, hypertension, and systemic inflammatory and coagulation disorders. Therefore, the current manuscript aims to review the main findings on PCOS and obesity/obesity-related disease (glucose derangements and cardiovascular disease risk factors).

Key message: Although there are no long-term data on the morbidity and mortality for cardiovascular disease in PCOS, it is advisable to perform a careful metabolic and cardiovascular assessment in women with PCOS in order to tailor the most suitable strategy to prevent cardiovascular disease.

Keywords: Cardiovascular disease; Environment; Lifestyle; Obesity; PCOS; Type 2 diabetes.

Publication types

  • Review

MeSH terms

  • Adult
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / prevention & control*
  • Combined Modality Therapy
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Female
  • Healthy Lifestyle
  • Humans
  • Insulin Resistance*
  • Models, Biological*
  • Obesity, Abdominal / complications
  • Obesity, Abdominal / ethnology
  • Obesity, Abdominal / physiopathology
  • Obesity, Abdominal / therapy*
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / ethnology
  • Polycystic Ovary Syndrome / physiopathology
  • Polycystic Ovary Syndrome / therapy*
  • Prevalence
  • Risk Factors
  • Weight Loss